Basic Information
Basic information for SOX2-OT-291-16aa-1
Peptide Name SOX2-OT-291-16aa-1
Genome Position chr3:181610906-181610929,181699598-181699621[+]
Species Human
Peptide Sequence MKCSLSIPGIAVAKLG
Peptide Length 16
Unique No (SOX2-OT-206-16aa,SOX2-OT-212-16aa,SOX2-OT-215-16aa,SOX2-OT-218-16aa-3,SOX2-OT-228-16aa,SOX2-OT-241-16aa,SOX2-OT-255-16aa,SOX2-OT-256-16aa,SOX2-OT-263-16aa-2,SOX2-OT-276-16aa-1,SOX2-OT-283-16aa-1,SOX2-OT-285-16aa-1,SOX2-OT-293-16aa-1,SOX2-OT-294-16aa-3,SOX2-OT-296-16aa-1,SOX2-OT-297-16aa-1,SOX2-OT-298-16aa-3,SOX2-OT-303-16aa-3,SOX2-OT-304-16aa-3)
Grand Average of Hydropathicity 1.0625
Relative Molecular Mass 1858.21
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000654538;SOX2-OT-291
Transcript Length 3844
Coding Ability 0.3455
DNA Sequence Corresponding to Peptide ATGAAATGTTCTCTTTCTATTCCAGGGATTGCAGTGGCAAAGCTAGGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :